Cell & Gene Therapy

gold arrow pointing upward forward
Biotech

Protara shares spike after bladder cancer data drop

Protara’s cell therapy elicited a 72% complete response rate for patients with bladder cancer, data that sent the biotech’s shares surging.
Gabrielle Masson Dec 5, 2024 2:30pm
Layoffs

Cash-strapped Medigene lays off 40%, pauses plan to enter clinic

Nov 26, 2024 6:52am
graphic of a larger shark chomping up a smaller one

Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts

Nov 26, 2024 6:00am
Digitally generated DNA fragment on a dark background

Patient put in critical condition by Neurogene gene therapy dies

Nov 22, 2024 3:57am
Novartis

Novartis signs $1.1B deal for muscular dystrophy biotech

Nov 21, 2024 8:19am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Novartis taps Vyriad’s viral vectors for in vivo T cell editing

Nov 20, 2024 12:00pm
More News

Neurogene stops Batten gene therapy after FDA denies request

Nov 19, 2024 6:30am

Regenxbio starts pivotal study for DMD gene therapy

Nov 18, 2024 2:24pm

CSL Behring shuts down California cell and gene therapy R&D site

Nov 18, 2024 8:35am

Neurogene acts as gene therapy puts person in critical condition

Nov 18, 2024 8:33am